Results 91 to 100 of about 6,336 (192)

Case Report: Use of telitacicept for ocular myasthenia gravis. [PDF]

Front Immunol
Yang A, Zhao J, Li F, Pang R, Zang W.
europepmc   +1 more source

Topical pyridostigmine for ocular myasthenia gravis: a translational hypothesis. [PDF]

Med Hypothesis Discov Innov Ophthalmol
Ing EB, Lim K, Davies NM, Lobenberg R, Harunur Rashid M, Le TS, Rullo J.   +6 more
europepmc   +1 more source

Miastenia grave y miastenia grave ocular

Revista Cubana de Oftalmología
La miastenia grave es una enfermedad caracterizada por debilidad y fatiga de los músculos voluntarios debido a una trasmisión anómala a nivel de la unión neuromuscular. La prevalencia es aproximadamente de 5 casos/100 000 personas.
Rosa María Naranjo Fernández, Yaimir Estévez Miranda, Teresita de Jesús Méndez Sánchez, Milagros D Dorrego Oduardo, Raúl Rúa Martínez   +4 more
doaj  

Delayed diagnosis of ocular myasthenia gravis in a patient with aponeurotic ptosis: A case report. [PDF]

SAGE Open Med Case Rep
Xie J, Zhang H, Ye J.
europepmc   +1 more source

Oral Presentation

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Untargeted serum metabolomic profiling in patients with generalized and ocular myasthenia gravis. [PDF]

BMC Ophthalmol
Wei B, Yuan H, He J, Hu Y, Li J, Wu X.
europepmc   +1 more source

ePoster

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Identification of Ocular and Systemic Predictors and Development of a Prediction Model in Ocular Myasthenia Gravis. [PDF]

Transl Vis Sci Technol
Cai Y, Tang T, Peng S, Gong D, Zhang R, Zhou Q.   +5 more
europepmc   +1 more source

Ocular Myasthenia Gravis: A Current Overview. [PDF]

Eye Brain, 2023
Behbehani R.
europepmc   +1 more source

ePosters Virtual

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source